United States Biotechnology & Medical Research

Acceleron Pharma Inc (XLRN)

Track

Ticker: XLRN Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 27 Sep 2021
Value US$597,699.00 | Price 236.07 | Shares 80,876 (+14.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-09-27 2021-09-27 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
80,876 +14.0%
236.07
US$597,699 		80,876 +14.0% 236.07 US$597,699
2021-04-21 2021-04-19 PlS Planned sale
4.2
MCCOURT Thomas A
Non-Executive Director
80,972 -18.3%
486.48
US$1,798,575 		80,972 -18.3% 486.48 US$1,798,575
2021-04-21 2021-04-19 PlS Planned sale
4.2
MCCOURT Thomas A
Non-Executive Director
70,011 -36.5%
336.91
US$4,457,155 		70,011 -36.5% 336.91 US$4,457,155
2021-04-21 2021-04-19 PlS Planned sale
4.2
MCCOURT Thomas A
Non-Executive Director
4,030 -35.3%
119.36
US$481,021 		4,030 -35.3% 119.36 US$481,021
2021-04-21 2021-04-19 PlS Planned sale
4.2
MCCOURT Thomas A
Non-Executive Director
2,127 -15.7%
118.39
US$251,816 		2,127 -15.7% 118.39 US$251,816
2021-04-05 2021-04-05 PlS Planned sale
Smith Karen L.
Non-Executive Director
641 -28.3%
141.15
US$90,477 		641 -28.3% 141.15 US$90,477
2021-04-05 2021-04-05 PlS Planned sale
Smith Karen L.
Non-Executive Director
11,223 -83.2%
140.13
US$1,572,679 		11,223 -83.2% 140.13 US$1,572,679
2021-04-02 2021-04-01 PlS Planned sale
4.3
Zakrzewski Joseph S
Non-Executive Director
1,600 -4.4%
135.67
US$217,072 		1,600 -4.4% 135.67 US$217,072
2021-04-02 2021-04-01 PlS Planned sale
4.3
Zakrzewski Joseph S
Non-Executive Director
1,700 -4.5%
135.22
US$229,874 		1,700 -4.5% 135.22 US$229,874
2021-04-02 2021-04-01 PlS Planned sale
4.3
Zakrzewski Joseph S
Non-Executive Director
6,596 -14.9%
134.27
US$885,645 		6,596 -14.9% 134.27 US$885,645
2021-04-02 2021-04-01 PlS Planned sale
4.3
Zakrzewski Joseph S
Non-Executive Director
104 -0.2%
132.61
US$13,791 		104 -0.2% 132.61 US$13,791
2021-03-04 2021-03-02 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
200 -1.0%
138.15
US$27,630 		200 -1.0% 138.15 US$27,630
2021-03-04 2021-03-02 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
600 -3.0%
137.12
US$82,272 		600 -3.0% 137.12 US$82,272
2021-03-04 2021-03-02 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
1,501 -6.9%
136.24
US$204,496 		1,501 -6.9% 136.24 US$204,496
2021-03-04 2021-03-02 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
2,699 -11.1%
135.48
US$365,661 		2,699 -11.1% 135.48 US$365,661
2021-01-06 2021-01-05 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
94 -0.1%
122.55
US$11,520 		94 -0.1% 122.55 US$11,520
2021-01-06 2021-01-05 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
764 -0.9%
122.46
US$93,559 		764 -0.9% 122.46 US$93,559
2021-01-06 2021-01-05 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
900 -1.1%
121.55
US$109,395 		900 -1.1% 121.55 US$109,395
2021-01-06 2021-01-05 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
2,500 -2.9%
120.52
US$301,300 		2,500 -2.9% 120.52 US$301,300
2021-01-06 2021-01-05 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
100 -0.6%
124.30
US$12,430 		100 -0.6% 124.30 US$12,430
2021-01-06 2021-01-05 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
56 -0.3%
122.93
US$6,884 		56 -0.3% 122.93 US$6,884
2021-01-06 2021-01-05 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
1,900 -10.4%
122.46
US$232,674 		1,900 -10.4% 122.46 US$232,674
2021-01-06 2021-01-05 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
4 -0.1%
123.50
US$494 		4 -0.1% 123.50 US$494
2021-01-06 2021-01-05 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
296 -4.8%
122.85
US$36,364 		296 -4.8% 122.85 US$36,364
2021-01-06 2021-01-05 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
499 -7.5%
121.89
US$60,823 		499 -7.5% 121.89 US$60,823
2021-01-06 2021-01-05 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
700 -9.6%
120.43
US$84,301 		700 -9.6% 120.43 US$84,301
2021-01-06 2021-01-04 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
4,624 -53.7%
126.15
US$583,318 		4,624 -53.7% 126.15 US$583,318
2021-01-06 2021-01-04 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
3,429 -28.5%
125.17
US$429,208 		3,429 -28.5% 125.17 US$429,208
2021-01-06 2021-01-04 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
1,947 -13.9%
123.90
US$241,233 		1,947 -13.9% 123.90 US$241,233
2021-01-06 2021-01-04 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
300 -3.9%
124.45
US$37,335 		300 -3.9% 124.45 US$37,335
2021-01-06 2021-01-04 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
667 -8.1%
124.47
US$83,021 		667 -8.1% 124.47 US$83,021
2021-01-06 2021-01-04 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
600 -6.8%
123.49
US$74,094 		600 -6.8% 123.49 US$74,094
2021-01-06 2021-01-04 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
200 -2.2%
125.49
US$25,098 		200 -2.2% 125.49 US$25,098
2021-01-06 2021-01-04 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
713 -7.3%
124.28
US$88,612 		713 -7.3% 124.28 US$88,612
2021-01-06 2021-01-04 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
800 -7.6%
123.54
US$98,832 		800 -7.6% 123.54 US$98,832
2020-12-15 2020-12-14 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
42,528 -79.1%
130.14
US$5,534,594 		42,528 -79.1% 130.14 US$5,534,594
2020-12-11 2020-12-11 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
3,100 -21.7%
125.00
US$387,500 		3,100 -21.7% 125.00 US$387,500
2020-12-11 2020-12-10 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
500 -4.3%
125.12
US$62,560 		500 -4.3% 125.12 US$62,560
2020-12-11 2020-12-09 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
3,872 -25.7%
125.03
US$484,116 		3,872 -25.7% 125.03 US$484,116
2020-10-13 2020-10-12 PlS Planned sale
Kearney Terrence C
Non-Executive Director
913 -15.1%
120.57
US$110,080 		913 -15.1% 120.57 US$110,080
2020-10-13 2020-10-12 PlS Planned sale
Kearney Terrence C
Non-Executive Director
16,210 -72.9%
119.78
US$1,941,634 		16,210 -72.9% 119.78 US$1,941,634
2020-10-13 2020-10-12 PlS Planned sale
Kearney Terrence C
Non-Executive Director
18,177 -45.0%
119.11
US$2,165,062 		18,177 -45.0% 119.11 US$2,165,062
2020-10-13 2020-10-12 PlS Planned sale
Kearney Terrence C
Non-Executive Director
2,200 -5.2%
117.82
US$259,204 		2,200 -5.2% 117.82 US$259,204
2020-09-15 2020-09-11 PlS Planned sale
4.2
MCCOURT Thomas A
Non-Executive Director
200 -4.3%
91.38
US$18,276 		200 -4.3% 91.38 US$18,276
2020-09-15 2020-09-11 PlS Planned sale
4.2
MCCOURT Thomas A
Non-Executive Director
13,896 -75.0%
90.64
US$1,259,533 		13,896 -75.0% 90.64 US$1,259,533
2020-09-15 2020-09-11 PlS Planned sale
4.2
MCCOURT Thomas A
Non-Executive Director
9,176 -33.1%
89.98
US$825,656 		9,176 -33.1% 89.98 US$825,656
2020-09-09 2020-09-08 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
929 -4.6%
89.85
US$83,471 		929 -4.6% 89.85 US$83,471
2020-09-09 2020-09-08 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
1,071 -5.1%
89.20
US$95,533 		1,071 -5.1% 89.20 US$95,533
2020-07-13 2020-07-09 S Sale
3.3
CELGENE CORP /DE/
Large shareholder
2,241 -0.0%
102.28
US$229,209 		2,241 -0.0% 102.28 US$229,209
2020-07-06 2020-07-01 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
1,100 -1.2%
99.42
US$109,362 		1,100 -1.2% 99.42 US$109,362
2020-07-06 2020-07-01 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
4,400 -4.6%
98.57
US$433,708 		4,400 -4.6% 98.57 US$433,708
2020-07-06 2020-07-01 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
9,534 -9.1%
97.43
US$928,898 		9,534 -9.1% 97.43 US$928,898
2020-07-06 2020-07-01 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
15,219 -12.7%
96.49
US$1,468,481 		15,219 -12.7% 96.49 US$1,468,481
2020-07-06 2020-07-01 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
13,047 -9.8%
95.85
US$1,250,555 		13,047 -9.8% 95.85 US$1,250,555
2020-07-06 2020-07-01 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
3,000 -2.2%
94.46
US$283,380 		3,000 -2.2% 94.46 US$283,380
2020-07-06 2020-07-01 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
3,700 -2.7%
93.53
US$346,061 		3,700 -2.7% 93.53 US$346,061
2020-07-06 2020-07-01 B Purchase
3.3
CELGENE CORP /DE/
Large shareholder
108,108 +1.6%
92.50
US$9,999,990 		108,108 +1.6% 92.50 US$9,999,990
2020-04-10 2020-04-09 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
17,226 -60.6%
88.19
US$1,519,161 		17,226 -60.6% 88.19 US$1,519,161
2020-04-10 2020-04-08 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
417 -1.9%
87.53
US$36,500 		417 -1.9% 87.53 US$36,500
2020-04-10 2020-04-08 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
1,100 -4.9%
86.69
US$95,359 		1,100 -4.9% 86.69 US$95,359
2020-04-10 2020-04-08 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
2,883 -11.3%
85.77
US$247,275 		2,883 -11.3% 85.77 US$247,275
2020-04-10 2020-04-08 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
700 -2.7%
84.62
US$59,234 		700 -2.7% 84.62 US$59,234
2020-04-10 2020-04-08 PlS Planned sale
Veness Adam M

SVP, General Counsel and Sec.

Officer
900 -3.3%
83.49
US$75,141 		900 -3.3% 83.49 US$75,141
2020-04-10 2020-04-08 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
3,703 -24.8%
87.50
US$324,012 		3,703 -24.8% 87.50 US$324,012
2020-04-10 2020-04-08 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
5,921 -28.4%
86.79
US$513,884 		5,921 -28.4% 86.79 US$513,884
2020-04-10 2020-04-08 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
15,410 -42.5%
85.80
US$1,322,178 		15,410 -42.5% 85.80 US$1,322,178
2020-04-10 2020-04-08 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
3,803 -9.5%
84.89
US$322,837 		3,803 -9.5% 84.89 US$322,837
2020-04-10 2020-04-08 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
5,037 -11.2%
83.68
US$421,496 		5,037 -11.2% 83.68 US$421,496
2020-04-10 2020-04-08 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F

SVP, CFO and Treasurer

Officer
2,900 -6.0%
82.83
US$240,207 		2,900 -6.0% 82.83 US$240,207
2020-02-14 2020-02-13 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
5 -0.0%
94.82
US$474 		5 -0.0% 94.82 US$474
2020-02-14 2020-02-13 PlS Planned sale
KANGO SUJAY

EVP, Chief Commercial Officer

Officer
590 -3.7%
94.09
US$55,513 		590 -3.7% 94.09 US$55,513
2020-01-03 2020-01-03 PlS Planned sale
Veness Adam M

VP, General Counsel and Sec.
875 -5.6%
51.23
US$44,826 		875 -5.6% 51.23 US$44,826
2020-01-03 2020-01-03 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
3,634 -5.1%
51.24
US$186,206 		3,634 -5.1% 51.24 US$186,206
2020-01-03 2020-01-03 PlS Planned sale
Dable Habib J

CEO and President

Executive Director
98 -0.1%
51.26
US$5,023 		98 -0.1% 51.26 US$5,023
2020-01-03 2020-01-03 PlS Planned sale
KANGO SUJAY

SVP, Chief Commercial Officer
11 -0.1%
51.27
US$564 		11 -0.1% 51.27 US$564
Explore more

More insider trading research around Acceleron Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America